<code id='054B14704B'></code><style id='054B14704B'></style>
      • <acronym id='054B14704B'></acronym>
      <center id='054B14704B'><center id='054B14704B'><tfoot id='054B14704B'></tfoot></center><abbr id='054B14704B'><dir id='054B14704B'><tfoot id='054B14704B'></tfoot><noframes id='054B14704B'>
      • <optgroup id='054B14704B'><strike id='054B14704B'><sup id='054B14704B'></sup></strike><code id='054B14704B'></code></optgroup>
        5. <b id='054B14704B'><label id='054B14704B'><select id='054B14704B'><dt id='054B14704B'><span id='054B14704B'></span></dt></select></label></b><u id='054B14704B'></u>
          <i id='054B14704B'><strike id='054B14704B'><tt id='054B14704B'><pre id='054B14704B'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / fashion / entertainment      
           
     
           
      
          entertainment 
           
      
           
      
           
       2025-09-30 21:42:31 
   
      
           
      
           
                        
          entertainment  
          
                                   
                 
                                      author：focus   
                                        
                                      
                                      Page View：122
                                  
                                    
          
                                   
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard																									Jason DeCrow/AP
          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.
          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.
          advertisement
          Humana’s stock fell by more than 2% on the news Wednesday morning.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe													Log In											
                      
                              
          
                                 Previous article：

                                
                                          In 'major milestone,' FDA approves first cell therapy for solid tumors
                                
                            
          Next article：  
                                      
                                          Sports medicine is finally prioritizing gender equality
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles